Related Experiment Video
Updated: Oct 6, 2025

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
Published on: June 16, 2011
Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift
Tao Li1, Zhimin Cui1,2, Yunfei Jia3,4
1Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, China.
Abstract:
Variants of SARS-CoV-2 continue to emerge, posing great challenges in outbreak prevention and control. It is important to understand in advance the impact of possible variants of concern (VOCs) on infectivity and antigenicity. Here, we constructed one or more of the 15 high-frequency naturally occurring amino acid changes in the receptor-binding domain (RBD) of Alpha, Beta, and Gamma variants. A single mutant of A520S, V367F, and S494P in the above three VOCs enhanced infectivity in ACE2-overexpressing 293T cells of different species, LLC-MK2 and Vero cells. Aggregation of multiple RBD mutations significantly reduces the infectivity of the possible three VOCs. Regarding neutralization, it is noteworthy that E484K, N501Y, K417N, and N439K predispose to monoclonal antibodies (mAbs) protection failure in the 15 high-frequency mutations. Most importantly, almost all possible VOCs (single RBD mutation or aggregation of multiple mutations) showed no more than a fourfold decrease in neutralizing activity with convalescent sera, vaccine sera, and immune sera of guinea pigs with different immunogens, and no significant antigenic drift was formed. In conclusion, our pseudovirus results could reduce the concern that the aggregation of multiple high-frequency mutations in the RBD of the spike protein of the three VOCs would lead to severe antigenic drift, and this would provide value for vaccine development strategies.
Insights
Emerging SARS-CoV-2 variants with multiple receptor-binding domain mutations show reduced infectivity but do not cause significant antigenic drift, easing concerns for vaccine development.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- SARS-CoV-2 variants of concern (VOCs) present challenges for infection control.
- Understanding the impact of mutations on infectivity and antigenicity is crucial for pandemic response.
Purpose of the Study:
- To assess the infectivity and neutralization of SARS-CoV-2 variants with high-frequency mutations in the receptor-binding domain (RBD).
- To evaluate the potential for antigenic drift in VOCs with combined RBD mutations.
Main Methods:
- Construction of pseudoviruses with single or multiple high-frequency amino acid changes in the RBD of Alpha, Beta, and Gamma variants.
- In vitro infectivity assays using ACE2-overexpressing cells, LLC-MK2, and Vero cells.
- Neutralization assays using convalescent sera, vaccine sera, and guinea pig immune sera.
Main Results:
- Single mutations (A520S, V367F, S494P) enhanced infectivity, while multiple mutations reduced it.
- Specific mutations (E484K, N501Y, K417N, N439K) were associated with reduced efficacy of monoclonal antibodies.
- Most VOCs showed minimal decrease in neutralizing activity against various human and animal sera, indicating no significant antigenic drift.
Conclusions:
- Aggregation of multiple RBD mutations in SARS-CoV-2 VOCs does not lead to significant antigenic drift.
- These findings are valuable for guiding vaccine development strategies against evolving SARS-CoV-2 strains.
Related Concept Videos
Genetic Drift
Mutation, Gene Flow, and Genetic Drift
Viral Mutations
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Point and Frameshift Mutations
Single Nucleotide Polymorphisms-SNPs

